DELRAY BEACH, Fla.--(BUSINESS WIRE)--XenaCare Holdings, Inc. (OTCBB:XCHO), a company specializing in the branding, marketing and retail distribution of consumer healthcare products including its over-the-counter (OTC) pain reliever, Cobroxin, has generated sales of $ 895,487 for the 1st Quarter of 2010. That is an $837,263 increase over First Quarter 2009.
